Terms: = Ovarian cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Staging
110 results:
1. RPL35A drives ovarian cancer progression by promoting the binding of YY1 to CTCF promoter.
Wu H; Xia L; Sun L; Li D; Liu X; Song H; Sheng J; Wang K; Feng Q
J Cell Mol Med; 2024 Mar; 28(6):e18115. PubMed ID: 38436544
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
[TBL] [Abstract] [Full Text] [Related]
3. NIR-II Fluorescence Imaging for the Detection and Resection of cancerous Foci and Lymph Nodes in Early-Stage Orthotopic and Advanced-Stage Metastatic ovarian cancer Models.
Pu T; Liu Y; Pei Y; Peng J; Wang Z; Du M; Liu Q; Zhong F; Zhang M; Li F; Xu C; Zhang X
ACS Appl Mater Interfaces; 2023 Jul; 15(27):32226-32239. PubMed ID: 37385963
[TBL] [Abstract] [Full Text] [Related]
4. ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract] [Full Text] [Related]
5. The Utility of Preoperative Serum CA125 Combined with HE4 to Predict Lymph Node Metastasis in Endometrial cancer.
Prueksaritanond N; Angsathapon S; Insin P
Gynecol Obstet Invest; 2023; 88(1):53-60. PubMed ID: 36596280
[TBL] [Abstract] [Full Text] [Related]
6. Effects of MFG-E8 expression on the biological characteristics of ovarian cancer cells via the AKT/mTOR/S6K signalling pathway.
Li N; Wang Y; Liu L; Wang P; Wu X
J Obstet Gynaecol; 2023 Dec; 43(1):2151354. PubMed ID: 36484512
[TBL] [Abstract] [Full Text] [Related]
7. Mitochondrial AAA protease gene associated with immune infiltration is a prognostic biomarker in human ovarian cancer.
Liao WT; Chu PY; Su CC; Wu CC; Li CJ
Pathol Res Pract; 2022 Dec; 240():154215. PubMed ID: 36423401
[TBL] [Abstract] [Full Text] [Related]
8. Squamous cell carcinoma in mature cystic teratoma of the ovary induced by human papillomavirus 16 infection: A case report and literature review.
Shi Z; Yang L; Bian C
Medicine (Baltimore); 2022 Sep; 101(38):e30667. PubMed ID: 36197169
[TBL] [Abstract] [Full Text] [Related]
9. Circ_0072995 drives cervical cancer development by regulating the miR-29a/WDR5 axis.
Song Z; Li H
J Obstet Gynaecol; 2022 Oct; 42(7):3342-3348. PubMed ID: 36168936
[TBL] [Abstract] [Full Text] [Related]
10. Circ_0067934 reduces JNK phosphorylation through a microRNA-545-3p/PPA1 axis to enhance tumorigenesis and cisplatin resistance in ovarian cancer.
Yin Y; Li J; Rong J; Zhang B; Wang X; Han H
Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):261-274. PubMed ID: 35179434
[TBL] [Abstract] [Full Text] [Related]
11. Rethinking the significance of surgery for uterine cervical cancer.
Shimada M; Tsuji K; Shigeta S; Nagai T; Watanabe Z; Tokunaga H; Kigawa J; Yaegashi N
J Obstet Gynaecol Res; 2022 Mar; 48(3):576-586. PubMed ID: 34908207
[TBL] [Abstract] [Full Text] [Related]
12. Past, Present, and Future of Serum Tumor Markers in Management of ovarian cancer: A Guide for the Radiologist.
Rao S; Smith DA; Guler E; Kikano EG; Rajdev MA; Yoest JM; Ramaiya NH; Tirumani SH
Radiographics; 2021 Oct; 41(6):1839-1856. PubMed ID: 34597221
[TBL] [Abstract] [Full Text] [Related]
13. Low Expression of Rasal2 Promotes Non-small Cell Lung cancer Metastasis through Ras/ERK Pathway.
Fan D; Yu S; Yang Y; Qu S
Biol Pharm Bull; 2021; 44(7):992-998. PubMed ID: 34193694
[TBL] [Abstract] [Full Text] [Related]
14. High FOXA1 immunohistochemical expression level associates with mucinous histology, favorable clinico-pathological prognostic parameters and survival advantage in epithelial ovarian cancer.
Sheta H; Abd El Hafez A; Saif M; Elsergany AR; Al Emam D; Abdelrazik MM
Pathologica; 2021 Apr; 113(2):102-114. PubMed ID: 34042091
[TBL] [Abstract] [Full Text] [Related]
15. Application of serum markers in diagnosis and staging of ovarian endometriosis.
Tang T; Lai H; Huang X; Gu L; Shi H
J Obstet Gynaecol Res; 2021 Apr; 47(4):1441-1450. PubMed ID: 33448139
[TBL] [Abstract] [Full Text] [Related]
16. KRT7 promotes epithelial‑mesenchymal transition in ovarian cancer via the TGF‑β/Smad2/3 signaling pathway.
An Q; Liu T; Wang MY; Yang YJ; Zhang ZD; Liu ZJ; Yang B
Oncol Rep; 2021 Feb; 45(2):481-492. PubMed ID: 33416175
[TBL] [Abstract] [Full Text] [Related]
17. Correlation analysis and clinical significance of CA125, HE4, DDI, and FDP in type II epithelial ovarian cancer.
Qiao L; Chen X; Xi X; Chen X; Zhang P; Dong H; Wu X; Chen X
Medicine (Baltimore); 2020 Dec; 99(49):e23329. PubMed ID: 33285710
[TBL] [Abstract] [Full Text] [Related]
18. Guideline No. 403: Initial Investigation and Management of Adnexal Masses.
Salvador S; Scott S; Glanc P; Eiriksson L; Jang JH; Sebastianelli A; Dean E
J Obstet Gynaecol Can; 2020 Aug; 42(8):1021-1029.e3. PubMed ID: 32736853
[TBL] [Abstract] [Full Text] [Related]
19. Primary Breast Carcinoma of the Vulva Metastatic to Lymph Nodes and Bones: A Case Report and Literature Review.
Ananthula A; Lockwood B; Savage J; Malak S; Chen C; Makhoul I; Pennisi A
Perm J; 2020; 24():. PubMed ID: 32097114
[TBL] [Abstract] [Full Text] [Related]
20. Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances.
Casey L; Singh N
Histopathology; 2020 Jan; 76(1):37-51. PubMed ID: 31846521
[TBL] [Abstract] [Full Text] [Related]
[Next]
